PACIRA BIOSCIENCES, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PACIRA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2026-06-30 was 0.00 shares.
- PACIRA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2026-03-31 was 2.24M shares.
- PACIRA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2025-12-31 was 2.00M shares.
- PACIRA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 1.98M shares.
- PACIRA BIOSCIENCES, INC. treasury stock, shares, acquired for fiscal 2025 was 5.94M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 6.23M shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 2.24M shares 10-Q · filed 2026-04-30 | |
| 2025-12-31 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 5.94M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 1.98M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |